Catalyst
Slingshot members are tracking this event:
Keryx Biopharmaceuticals announced an interruption in the supply of Auryxia (ferric citrate) tablets due to a production-related issue converting active pharmaceutical ingredient (API) to finished
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| KERX |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 01, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Ferric Citrate, Api, Supply, Interruption, Cyclobenzaprine, Hyperphosphatemia
